Cara Mathews

8PUBLICATIONS
101CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 11, 2026
First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma.

|Jan 09, 2025
Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial.

Jyoti Mayadev, Dmitriy Zamarin, Wei Deng

|May 22, 2024
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study.

Charles N Landen, Ronald J Buckanovich, Michael W Sill

|Jan 09, 2024
Normal Risk Ovarian Screening Study: 21-Year Update.

Chae Young Han, Karen H Lu, Gwen Corrigan

|Aug 31, 2023
Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study.

Ignace Vergote, Els Van Nieuwenhuysen, Roisin E O'Cearbhaill

|Jun 26, 2023
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study.

Ana Oaknin, Bhavana Pothuri, Lucy Gilbert

Pageof 2

Frequent Collaborators

3 joint publications

Susana Banerjee

2 joint publications

Roisin O'Cearbhaill

2 joint publications

Heather A Lankes

2 joint publications

Joyce Liu